Literature DB >> 27431011

Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model.

Radha Ramakrishnan1, Sathy V Balu-Iyer2.   

Abstract

A major complication in the replacement therapy of Factor VIII (FVIII) for Hemophilia A is the development of unwanted immune responses. Previous studies from our laboratory have shown that pretreatment of FVIII in the presence of phosphatidylserine (PS) resulted in hyporesponsiveness to subsequent administration of FVIII alone, due to the ability of PS to convert an immunogen to a tolerogen. We investigated the importance of biophysical properties of PS liposomes on its ability to convert an immunogen to a tolerogen. PS particles were prepared differing in size, protein-lipid topology, lamellarity, and % association to FVIII keeping the composition of the particle same. PS particles were prepared in 2 different sizes with differing biophysical properties: smaller particles in the nanometer range (200 nm) and larger size particles in the micron range (2 μm). Hemophilia A animals treated with both the nanometer and micron size PS particles showed a significant reduction in anti-FVIII antibody titers when compared to animals receiving free FVIII alone. Upon rechallenge with free FVIII animals that received FVIII along with the nanometer size particle continued to show reduced antibody responses. Animals receiving the micron size particle showed a slight increase in titers although they remained significantly lower than the free FVIII treated group. Upon culture with bone marrow derived dendritic cells, the nanometer size particle showed a reduction in CD40 expression and an increase in transforming growth factor-β cytokine production, which was not observed with the micron size particle. These results show that biophysical properties of PS play an important role in tolerance.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  immune tolerance; immunology; lipids; phosphatidylserine; protein delivery

Mesh:

Substances:

Year:  2016        PMID: 27431011      PMCID: PMC5021571          DOI: 10.1016/j.xphs.2016.06.008

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  35 in total

Review 1.  A blast from the past: clearance of apoptotic cells regulates immune responses.

Authors:  John Savill; Ian Dransfield; Chris Gregory; Chris Haslett
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

Review 3.  Vaccines that facilitate antigen entry into dendritic cells.

Authors:  Anita Gamvrellis; David Leong; Jennifer C Hanley; Sue D Xiang; Patricia Mottram; Magdalena Plebanski
Journal:  Immunol Cell Biol       Date:  2004-10       Impact factor: 5.126

4.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

5.  TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells.

Authors:  Lee A Albacker; Piia Karisola; Ya-Jen Chang; Sarah E Umetsu; Meixia Zhou; Omid Akbari; Norimoto Kobayashi; Nicole Baumgarth; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

6.  The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.

Authors:  B Verbruggen; I Novakova; H Wessels; J Boezeman; M van den Berg; E Mauser-Bunschoten
Journal:  Thromb Haemost       Date:  1995-02       Impact factor: 5.249

7.  Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor.

Authors:  S-Y Park; M-Y Jung; H-J Kim; S-J Lee; S-Y Kim; B-H Lee; T-H Kwon; R-W Park; I-S Kim
Journal:  Cell Death Differ       Date:  2007-10-26       Impact factor: 15.828

8.  Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A.

Authors:  Karthik Ramani; Razvan D Miclea; Vivek S Purohit; Donald E Mager; Robert M Straubinger; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2008-04       Impact factor: 3.534

9.  Phagocytosis of antigens by Langerhans cells in vitro.

Authors:  C Reis e Sousa; P D Stahl; J M Austyn
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

Review 10.  Phospholipids: key players in apoptosis and immune regulation.

Authors:  Ricardo A Chaurio; Christina Janko; Luis E Muñoz; Benjamin Frey; Martin Herrmann; Udo S Gaipl
Journal:  Molecules       Date:  2009-11-30       Impact factor: 4.411

View more
  2 in total

1.  Phosphatidylserine Is Not Just a Cleanup Crew but Also a Well-Meaning Teacher.

Authors:  Fiona Y Glassman; Jennifer L Schneider; Radha Ramakrishnan; Robert K Dingman; Murali Ramanathan; Richard B Bankert; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2018-04-09       Impact factor: 3.534

Review 2.  Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance.

Authors:  Takashi Kei Kishimoto; Roberto A Maldonado
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.